Welcome to medications.com

Zanaflex News

Acorda Therapeutics Q4 Loss Widens On Expenses - RTT News

The company reported gross sales of Zanaflex Capsules of $11.8 million and gross sales of Zanaflex of $1.0 million, providing combined gross sales of $12.8 ...

http://www.rttnews.com/sp/breakin... | Posted: Mon Feb 11 07:21:17 -0500 2008

Acorda Sinks on Forecast Wider 2008 Loss - Forbes

In the same SEC filing, Acorda said it expects to post a loss of $14 million during the fourth quarter, as sales of the muscle relaxant Zanaflex reached $12 ...

http://www.forbes.com/feeds/ap/20... | Posted: Wed Feb 06 19:03:49 -0500 2008

Conditional plea entered - Bismarck Tribune

... hydrocodone and cyclobenzaprine at a Washburn drugstore; the name "Melissa Anderson" to acquire hydrocodone and zanaflex from a Turtle Lake drugstore; ...

http://www.bismarcktribune.com/ar... | Posted: Sat Feb 23 05:08:33 -0500 2008

Conditional plea entered - Bismarck Tribune

... hydrocodone and cyclobenzaprine at a Washburn drugstore; the name "Melissa Anderson" to acquire hydrocodone and zanaflex from a Turtle Lake drugstore; ...

Posted: Sat Feb 23 05:08:33 -0500 2008

Conditional plea entered - Bismarck Tribune

... hydrocodone and cyclobenzaprine at a Washburn drugstore; the name "Melissa Anderson" to acquire hydrocodone and zanaflex from a Turtle Lake drugstore; ...

Posted: Sat Feb 23 05:08:33 -0500 2008

Acorda's Next Hurdle - Smartmoney.com

He foresees earnings of 90 cents a share in 2010, based on early Fampridine sales and revenue from Acorda's only other product, Zanaflex, which helps MS ...

http://www.smartmoney.com/barrons... | Posted: Thu Jan 24 16:08:59 -0500 2008

Out of the Gate: Acorda Therapeutics - Forbes

Acorda's only drug on the market is Zanaflex, a muscle relaxant. The company has two other drug candidates in preclinical development, and a third in the ...

http://www.forbes.com/feeds/ap/20... | Posted: Mon Jan 28 10:16:40 -0500 2008

Acorda Therapeutics Q4 Loss Widens On Expenses - Trading Markets (press release)

The company reported gross sales of Zanaflex Capsules of $11.8 million and gross sales of Zanaflex of $1.0 million, providing combined gross sales of $12.8 ...

http://www.tradingmarkets.com/.si... | Posted: Mon Feb 11 07:24:52 -0500 2008

Earnings Roundup: Loews, Napco - Forbes

... Therapeutics Inc. said Monday its fourth-quarter loss widened on higher operating expenses, but sales of its drug Zanaflex helped drive revenue higher. ...

http://www.forbes.com/feeds/ap/20... | Posted: Mon Feb 11 15:38:52 -0500 2008

Acorda Therapeutics, Inc. Announces Exercise of Option by Underwriters - PharmaLive.com (press release)

The Company's marketed products include Zanaflex Capsules(R) (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ...

http://www.medadnews.com/News/Ind... | Posted: Thu Feb 14 07:36:54 -0500 2008




ADVERTISEMENT
© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com